By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Sarajevo TimesSarajevo TimesSarajevo Times
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Search
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Reading: WHO: Causal Relationship between the Vaccine and the occurrence of Blood Clots is not confirmed
Share
Font ResizerAa
Sarajevo TimesSarajevo Times
Font ResizerAa
  • HOME
  • POLITICS
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
  • SPORT
  • ARTS
  • W&N
Search
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Follow US
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2012 Sarajevo Times. All rights reserved.
Sarajevo Times > Blog > Uncategorized > WHO: Causal Relationship between the Vaccine and the occurrence of Blood Clots is not confirmed
Uncategorized

WHO: Causal Relationship between the Vaccine and the occurrence of Blood Clots is not confirmed

Published: April 8, 2021
Share
SHARE

The COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) has reviewed reports of rare cases of blood clots with low platelets following vaccination with the AstraZeneca COVID-19 vaccine (including Covishield) since their onset a few weeks ago.

At its most recent meeting on 7 April, 2021, the subcommittee reviewed latest information from the European Medicines Agency along with information from the United Kingdom’s Medicines and other Health products Regulatory Agency (MHRA), and other Member States and noted the following:

Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed. Specialised studies are needed to fully understand the potential relationship between vaccination and possible risk factors.

The GACVS subcommittee will continue to gather and review further data, as it has done since the beginning of the COVID vaccine programme.

It is important to note that whilst concerning, the events under assessment are very rare, with low numbers reported among the almost 200 million individuals who have received the AstraZeneca COVID-19 vaccine around the world.

Rare adverse events following immunizations should be assessed against the risk of deaths from COVID-19 disease and the potential of the vaccines to prevent infections and reduce deaths due to diseases. In this context, it should be noted that as of today, at least 2.6 million people have died of COVID-19 disease worldwide.

Side effects within two- or three-days following vaccination, the majority of which are mild and local in nature, are expected and common. However, individuals who experience any severe symptoms – such as shortness of breath, chest pain, leg swelling, persistent abdominal pain, neurological symptoms, such as severe and persistent headaches or blurred vision, tiny blood spots under the skin beyond the site of the injection – from around four to 20 days following vaccination, should seek urgent medical attention. Clinicians should be aware of relevant case definitions and clinical guidance for patients presenting thrombosis and thrombocytopaenia following COVID-19 vaccination. To this end, the GACVS subcommittee also suggested that a committee of clinical experts including haematologists and other specialists is convened, for advice on clinical diagnosis and case management. 

Active surveillance, including sentinel site / hospital case-based investigations should be considered, to further characterise these rare events. WHO has developed template protocols that countries could adapt for such studies. The GACVS will meet again next week to review additional data and will be issuing further recommendations as relevant

WHO is carefully monitoring the rollout of all COVID-19 vaccines and will continue to work closely with countries to manage potential risks, and to use science and data to drive response and recommendations.

In extensive vaccination campaigns, it is normal for countries to identify potential adverse events following immunization. This does not necessarily mean that the events are linked to vaccination itself, but they must be investigated to ensure that any safety concerns are addressed quickly. Vaccines, like all medicines, can have side effects. The administration of vaccines is based on a risk versus benefit analysis.

Statement by the EU Heads of Missions on protests in Bosnia and Herzegovina
Dzumhur to play against the best Tennis Player in the World
The Government of FBiH to borrow 50 million BAM in Commercial Banks this Month?
From Croatia to BiH and vice versa: Pedophiles, Criminals, controversial Entrepreneurs use dual Citizenship as a Ticket to Freedom
Proposal to investigate alleged Abuses during Vaccination in Sarajevo was not accepted
Share This Article
Facebook Whatsapp Whatsapp Telegram Threads Bluesky Email Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article Deeper Cooperation Needed to End COVID-19, Economic Scarring
Next Article The EU Disburses SDR141 Million to the IMF’s Catastrophe Containment and Relief Trust
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Stay Connected

10.2KFollowersLike
10.1KFollowersFollow
414FollowersFollow

Latest News

Barbarez: It is a Privilege to have the Opportunity to compete against the best
November 20, 2026
Blanusa: SDS will not be Part of the RS Government
November 20, 2026
BiH supports the EU Position on establishing a Nuclear-weapon-Free Zone in the Middle East
November 20, 2026
The Prosecution is asking a Ban from performing Duties for Niksic, Isak and Munjic
November 20, 2026
The City of Sarajevo after being deleted as the Owner of the City Hall: We are not here illegally, we have invested Millions in the Renovation
November 20, 2026
Regional Agreement Signed, Seasonal Ski Passes from BiH Will Be Valid in Serbia, Slovenia, and Montenegro
November 20, 2026
Senate Committee Approves Ronald Johnson’s Nomination for the US Ambassador to BiH
November 20, 2026
World Phenomenon in Herzegovina: 136 Human Fish found in Golubinka Cave
November 20, 2026
Member of BiH Presidency Denis Becirovic holds separate Meetings with Ambassadors of Austria and Sweden
November 20, 2026
Salkic: SDA Return to Power in Republika Srpska is difficult to implement
November 20, 2026
Sarajevo TimesSarajevo Times
Follow US
© 2012 Sarajevo Times. All Rights Reserved.
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?